Tien-Li Lee - Chief Executive Officer, Director, 10%+ Owner at Aardvark Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director, 10%+ Owner
Issuer Symbol
AARD on Nasdaq
All Insider Reports
All Insider Reports

Tien-Li Lee - trading volume in the past year for Aardvark Therapeutics, Inc.

Holdings reported by Tien-Li Lee for Aardvark Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,551,613 $22,475,114 $14.48 11 Dec 2025 Direct
Common Stock 1,474,028 $16,007,944 $10.86 11 Dec 2025 By Spouse
Stock option (right to buy) 203,851 09 Feb 2026 Direct Common Stock
Series A Convertible Preferred Stock 0 14 Feb 2025 Direct Common Stock

Transactions reported by Tien-Li Lee for Aardvark Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.